Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)

Clinical trial NCT06923345 · RECRUITING

Trial details

NCT number: NCT06923345
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Neoadjuvant Therapies Immune Checkpoint Therapy Radiotherapy

Start date: 2025-03-31
Primary completion: 2027-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.